Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults

The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus

Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma

Transcriptome Analysis of Natural Killer Cells in Response to Newcastle Disease Virus Infected Hepatocellular Carcinoma Cells

Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment

Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response

Inhibition of Tumor Growth and Metastasis by Newcastle Disease Virus Strain P05 in a Breast Cancer Mouse Model

Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer

Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022

Immunotherapy for the treatment of pediatric brain tumors: a narrative review